Bedside to bench: Betting on B cells in multiple sclerosis

Nature Medicine

Volumn 14, Issue 6, 2008, Pages 615-616

  Link, Hans ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON; GLATIRAMER; IMMUNOGLOBULIN G; NATALIZUMAB; RITUXIMAB;

ANTIGEN PRESENTING CELL; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CEREBROSPINAL FLUID; DENDRITIC CELL; GLIA; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; MACROPHAGE; MONONUCLEAR CELL; MULTIPLE SCLEROSIS; NONHUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; UNSPECIFIED SIDE EFFECT;

ANTIBODIES, MONOCLONAL; B-LYMPHOCYTES; CLINICAL TRIALS, PHASE II AS TOPIC; CLINICAL TRIALS, PHASE III AS TOPIC; HUMANS; LYMPHOCYTE ACTIVATION; MULTIPLE SCLEROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECURRENCE;

EID: 44949090545     PISSN: 10788956     EISSN: 1546170X     Source Type: Journal    
DOI: 10.1038/nm0608-615     Document Type: Note

References (8)

1. Hauser, S.L. et al. N. Engl. J. Med. 358, 676-688 (2008).
2. Maloney, D.G. et al. Blood 90, 2188-2195 (1997).
3. Cross, A.H., Stark, J.L., Lauber, J., Ramsbottom, M.J. & Lyons, J.-A. J. Neuroimmunol. 180, 63-70 (2006).
4. Akiba, H. et al. J. Immunol. 162, 7058-7066 (1999).
5. Liossis, S.-N.C. & Sfikakis, P.P. Clin. Immunol. published online, doi: 10.1016/j.clim.2008.0.011 (10 March 2008).
6. O'Neill, B.P., Vernino, S., Dogan, A. & Giannini, C. Neuro-oncol. 9, 364-369 (2007).
7. Giovannoni, G. & Ebers, G. Curr. Opin. Neurol. 20, 261-268 (2007).
8. Serafini, B. et al. J. Exp. Med. 204, 2899-2912 (2007).